Monitoring the Session

SB 88

Zaffirini Bill Requires Cytomegalovirus Test For Every Texas Newborn

Filed

Verdict: No flags

No flagsInitial review
Sen. Judith ZaffiriniDSenate 21

Initial review · graded Nov 9, 2026 · How we grade

Caption

relating to newborn or infant testing for congenital cytomegalovirus.

Caption from analyzed text · version I.

Summary

Hospitals test every newborn for the virus with the hearing screening. Parents may decline. Starts 2027.

This bill requires hospitals and other birthing facilities to test every newborn for congenital cytomegalovirus, a virus passed from mother to baby, along with the hearing screening they already must do before the baby goes home. It touches birthing facilities, new parents, and the state health department, which must keep data on each baby tested. Parents must be told about the test at admission and may decline it, and the bill drops an existing subsection of the related testing law and starts on September 1, 2027.

Labels

Labels: ZOMBIE BILL. Died 2 times: 88R SB 1285 by Sen. Johnson (Died in committee) and 89R HB 4882 by Rep. Shofner (Did not pass). Checked against 88R and 89R only.BACK FROM THE DEAD. Same text as a bill filed before that died: 88R SB 1285 by Sen. Johnson (Died in committee) and 89R HB 4882 by Rep. Shofner (Did not pass). Filed in 3 sessions, counting this one. Checked against 88R and 89R only.TRY NO. 3. Filed in 3 sessions: 88R, 89R and 90R. Checked against 88R and 89R only.

Receipt

The receipt

90R-SB88 · 2026-11-09

SOLD BY

ITEM

relating to newborn or infant testing for congenital cytomegalovirus.

WHAT IT DOES

Hospitals test every newborn for the virus with the hearing screening. Parents may decline. Starts 2027.

This bill requires hospitals and other birthing facilities to test every newborn for congenital cytomegalovirus, a virus passed from mother to baby, along with the hearing screening they already must do before the baby goes home. It touches birthing facilities, new parents, and the state health department, which must keep data on each baby tested. Parents must be told about the test at admission and may decline it, and the bill drops an existing subsection of the related testing law and starts on September 1, 2027.

CHARGES

[ ] NONE FOUND

TOTAL

No fiscal note in the loaded record.

HISTORY

  1. Received by the Secretary of the Senate
  2. Filed
FILED UNDER

No verified beat found.

No flags

THANK YOU FOR CHECKING THE RECEIPT

CAMPAIGN PAID FOR BY

CAMPAIGN PAID FOR BY

Donors

Not tied to this bill.

Sources

The author's campaign account only. Own money and internal transfers are separate on the member page.

Derived itemized flow · Jul 1, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Carlos M. Zaffirini Jr$110,000.00
Killam Development Ltd.$72,700.00

Killam Development Ltd.

$72,700.00

Cash
$10,000.00
Paid by others
$62,700.00
Total
$72,700.00
advertising $33,000.00media $29,700.00

Also funds 3 other sitting lawmakers.

Derived recipient stock · Dec 9, 2024 to Sep 28, 2026. State data as of Nov 4, 2026.

Name match, not a verified identity: normalized filed name and state.

Sources

Derived itemized flow · Dec 16, 2025 to Aug 20, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101011018, 101057658.

Texas Trial Lawyers Association PAC$60,000.00

Texas Trial Lawyers Association PAC

$60,000.00

Cash
$60,000.00
Paid by others
$0.00
Total
$60,000.00

Also funds 137 other sitting lawmakers.

Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Nov 11, 2024 to Aug 31, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100959783, 100987492, 101011018, 101035338, 101057658.

Money

Missing data does not establish zero giving. Display amounts are rounded.

×

Killam Development Ltd.

$72,700.00

Cash
$10,000.00
Paid by others
$62,700.00
Total
$72,700.00
advertising $33,000.00media $29,700.00

Also funds 3 other sitting lawmakers.

Derived recipient stock · Dec 9, 2024 to Sep 28, 2026. State data as of Nov 4, 2026.

Name match, not a verified identity: normalized filed name and state.

Sources

Derived itemized flow · Dec 16, 2025 to Aug 20, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101011018, 101057658.

×

Texas Trial Lawyers Association PAC

$60,000.00

Cash
$60,000.00
Paid by others
$0.00
Total
$60,000.00

Also funds 137 other sitting lawmakers.

Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Nov 11, 2024 to Aug 31, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100959783, 100987492, 101011018, 101035338, 101057658.

Votes

No floor vote loaded for this bill.

Fiscal

No fiscal note in the loaded record.

How this was graded

Analysis of text version I by a super-expensive superintelligence, Nov 9, 2026, against the published rubric.

FILED BEFORE

Filed 3 times: 88R, 89R and now. Checked against 88R and 89R only.

88R SB 1285

by Sen. Johnson, different lead author · Died in committee · same text

Introduced text

Last action, Apr 26, 2023: Left pending in committee

Relating to newborn or infant testing for congenital cytomegalovirus.

Caption, 88R bill history

89R HB 4882

by Rep. Shofner, different lead author · Did not pass · same text

Introduced text

Last action, May 19, 2025: Received from the House

Relating to newborn or infant testing for congenital cytomegalovirus.

Caption, 89R bill history

Sources

Texas Senate · Filed Nov 9, 2026

11/09/2026 S Filed

Texas Legislature Online · Introduced

Data snapshot Nov 10, 2026 at 2:39 AM CST. Grades, charges, quotes and corrections follow the published record.

Subjects

Health--Other Diseases & Medical Conditions

Minors--Health & Safety

BLOOD & MEDICAL TESTS

PARENTAL CONSENT

PREGNANCY & CHILDBIRTH

Text

The text as introduced · 355 words

90R1227 JG-F

By: Zaffirini
S.B. No. 88

A BILL TO BE ENTITLED

AN ACT

relating to newborn or infant testing for congenital

cytomegalovirus.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. The heading to Section 47.003, Health and Safety

Code, is amended to read as follows:

Sec. 47.003. NEWBORN OR INFANT HEARING SCREENING, TRACKING,

AND INTERVENTION PROGRAM ; TESTING FOR CONGENITAL CYTOMEGALOVIRUS .

SECTION 2. Section 47.003, Health and Safety Code, is

amended by amending Subsections (a), (a-1), and (c) and adding

Subsection (g) to read as follows:

(a) A birthing facility, through a program certified by the

department under Section 47.004, shall perform, either directly or

through a referral to another program certified under that section,

a hearing screening for the identification of hearing loss and a

test for congenital cytomegalovirus on each newborn or infant born

at the facility before the newborn or infant is discharged from the

facility unless:

(1) the parent declines the screening or test ;

(2) the newborn or infant is transferred to another

facility before the screening or test is performed;

(3) the screening or test has previously been

completed; or

(4) the newborn was discharged from the birthing

facility not more than 10 hours after birth and a referral for the

newborn was made to a program certified under Section 47.004 at

another birthing facility or operated by a physician or other

health care provider.

(a-1) The birthing facility shall inform the parents during

admission that:

(1) the facility is required by law to :

(A) screen a newborn or infant for hearing loss ;

and

(B) conduct a test for congenital

cytomegalovirus ; and

(2) the parents may decline both the screening and the

test required under Subdivision (1) .

(c) Subject to Section 47.008, the department shall

maintain data and information on each newborn or infant who

receives a hearing screening or congenital cytomegalovirus test

under Subsection (a).

(g) In this section, "congenital cytomegalovirus" has the

meaning assigned by Section 46.001.

SECTION 3. Section 47.0032(b), Health and Safety Code, is

repealed.

SECTION 4. This Act takes effect September 1, 2027.